Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Clare Proudfoot, Raju Gautam, Joaquim Cristino, Rumjhum Agrawal, Lalit Thakur & Keith Tolley. Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review. The European Journal of Health Economics (2023) 24:453–467.